Why did 1643.HK stock spike today?

1643.HK stock rose intraday on 03 Feb 2026 largely from momentum and heavy buying rather than a clear company release. High relative volume and sector flows into small-cap healthcare names amplified the move.

What are the valuation metrics for 1643.HK stock?

Modern Chinese Medicine shows PE **21.75**, EPS **HK$0.04**, PB near **0.96**, and a strong current ratio **8.53**. These indicate modest earnings valuation with a solid balance sheet but weak cash flow.

What is Meyka AI's forecast for 1643.HK stock?

Meyka AI's forecast model projects **HK$0.90** in one year, **HK$1.42** in three years, and **HK$1.92** in five years versus the current **HK$0.94**; these are model projections and not guarantees.

Should I trade 1643.HK stock after the intraday gain?

Intraday traders should watch confirmation above **HK$1.00** with sustained volume and monitor RSI at **70.37**. Long-term investors should assess upcoming earnings and cash flow before increasing exposure.

HK Stocks

1643.HK Modern Chinese Medicine HKSE +28.77% intraday 03 Feb 2026: watch RSI

ByHuzaifa Zahoor February 3, 2026February 3, 2026

The 1643.HK stock surged 28.77% intraday on 03 Feb 2026, trading at HK$0.94 on the HKSE in Hong Kong as volume spiked to 3,522,000.00 shares. The move lifted the share price above the 50-day average of HK$0.61 and the 200-day average of HK$0.58, signalling a breakout that traders are watching for follow-through and confirmation.